These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 20128781
1. Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer. Ahyai SA, Zacharias M, Isbarn H, Steuber T, Eichelberg C, Köllermann J, Fisch M, Karakiewicz PI, Huland H, Graefen M, Chun FK. BJU Int; 2010 Aug; 106(4):478-83. PubMed ID: 20128781 [Abstract] [Full Text] [Related]
2. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT. J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984 [Abstract] [Full Text] [Related]
4. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951 [Abstract] [Full Text] [Related]
9. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Chun FK, Briganti A, Jeldres C, Gallina A, Erbersdobler A, Schlomm T, Walz J, Eichelberg C, Salomon G, Haese A, Currlin E, Ahyai SA, Bénard F, Huland H, Graefen M, Karakiewicz PI. Eur J Cancer; 2007 Feb; 43(3):536-43. PubMed ID: 17222546 [Abstract] [Full Text] [Related]
11. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system. van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA. BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608 [Abstract] [Full Text] [Related]
12. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era. Isbarn H, Wanner M, Salomon G, Steuber T, Schlomm T, Köllermann J, Sauter G, Haese A, Heinzer H, Huland H, Graefen M. BJU Int; 2010 Jul; 106(1):37-43. PubMed ID: 20002667 [Abstract] [Full Text] [Related]
13. Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy. Resnick MJ, Canter DJ, Guzzo TJ, Magerfleisch L, Tomaszewski JE, Brucker BM, Bergey MR, Sonnad SS, Wein AJ, Malkowicz SB. BJU Int; 2010 May; 105(10):1377-80. PubMed ID: 19888981 [Abstract] [Full Text] [Related]
20. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience. Xylinas E, Drouin SJ, Comperat E, Vaessen C, Renard-Penna R, Misrai V, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Roupret M. BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]